Enigma Diagnostics secures additional Technology Strategy Board funding for MDR-TB assay
Enigma Diagnostics, a leader in molecular diagnostic point-of-care infectious disease testing, announces that it has been awarded a second grant from the UK’s innovation agency, the Technology Strategy Board. This grant will support further development of its test for multidrug-resistant tuberculosis (MDR-TB) on its CE Marked Enigma® Mini Laboratory (ML) system.
Read the full press release here.
Source: Enigma Diagnostics